SCHEMBL28418228

SCHEMBL28418228

CC(C)C(N)C(=O)N(O)c1nc(C(N)=O)nc2nc[nH]c12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.37
▸ CDK2 P24941 8/20 0.33
▸ CDK1 P06493 7/20 0.33
▸ CCNB1 P14635 7/20 0.33
▸ CCNA2 P20248 7/20 0.33
▸ CCNA1 P78396 7/20 0.33
▸ MGMT P16455 3/20 0.33
▸ PIK3CA P42336 1/20 0.32
▸ PIK3CG P48736 1/20 0.32
▸ GDA Q9Y2T3 2/20 0.32
▸ PDPK1 O15530 2/20 0.31
▸ CHEK1 O14757 1/20 0.31
▸ AURKA O14965 1/20 0.31
▸ CHEK2 O96017 1/20 0.31
▸ HSP90AA1 P07900 1/20 0.31
▸ HSP90AB1 P08238 1/20 0.31
▸ PRKACA P17612 1/20 0.31
▸ CCNE1 P24864 1/20 0.31
▸ MARK3 P27448 1/20 0.31
▸ RPS6KA3 P51812 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31360592 1.00 CYP1A2 (0.37) CYP1A2CDK2CDK1CCNB1CCNA2
SCHEMBL29002285 0.81 CYP1A2 (0.35) CYP1A2CDK2CDK1CCNB1CCNA2
SCHEMBL31360537 0.81 CYP1A2 (0.35) CYP1A2CDK2CDK1CCNB1CCNA2
SCHEMBL31511880 0.75 HTT (0.39) CYP1A2CDK2CDK1CCNB1CCNA2
SCHEMBL30454201 0.70 GDA (0.37) CYP1A2CDK2CDK1CCNB1CCNA2
SCHEMBL29116496 0.70 GDA (0.37) CYP1A2CDK2CDK1CCNB1CCNA2
SCHEMBL31360412 0.69 CYP1A2 (0.37) CYP1A2CDK2CDK1CCNB1CCNA2
SCHEMBL28688022 0.69 CYP1A2 (0.37) CYP1A2CDK2CDK1CCNB1CCNA2
SCHEMBL27461919 0.69 GDA (0.58) CYP1A2CDK2MGMTGDAPDPK1
SCHEMBL28141587 0.69 DPP4 (0.42) CYP1A2CDK2MGMTPIK3CAPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119751285-A Lipid compounds and lipid nanoparticle compositions 中生复诺健生物科技(上海)有限公司 2025-04-04 — — CN disclosed
CN-116829578-B Polynucleotides encoding interleukin-12 (IL-12) and compositions and methods related thereto 苏州艾博生物科技有限公司 2025-03-21 — — CN disclosed
CN-119654141-A Lipid nanoparticle compositions 苏州艾博生物科技有限公司 2025-03-18 — — CN disclosed
CN-117083291-B Coronavirus nucleic acid vaccine based on sequences derived from SARS-CoV-2 Delta strain 苏州艾博生物科技有限公司 2025-02-28 — — CN disclosed
CN-119451976-A Mutant fragments of VZV glycoprotein E 苏州艾博生物科技有限公司 2025-02-14 — — CN disclosed
CN-119137160-A Nucleic acid vaccine for Respiratory Syncytial Virus (RSV) 苏州艾博生物科技有限公司 2024-12-13 — — CN disclosed
CN-117580587-B Coronavirus nucleic acid vaccine based on sequences derived from SARS-CoV-2 Omikovia strain 苏州艾博生物科技有限公司 2024-10-15 — — CN disclosed
CN-118715201-A Lipid compounds and lipid nanoparticle compositions 苏州艾博生物科技有限公司 2024-09-27 — — CN disclosed
CN-118697900-A Method for preparing lipid nanoparticles 摩登纳特斯有限公司 2024-09-27 — — CN disclosed
CN-118647397-A Polynucleotide composition and use thereof 辉瑞公司 2024-09-13 — — CN disclosed
CN-116829578-A Polynucleotides encoding interleukin-12 (IL-12) and compositions and methods related thereto 苏州艾博生物科技有限公司 2023-09-29 — — CN disclosed
CN-116670267-A Tetravalent mRNA vaccine for influenza virus 苏州艾博生物科技有限公司 2023-08-29 — — CN disclosed
CN-116472275-A Lipid compounds and lipid nanoparticle compositions 苏州艾博生物科技有限公司 2023-07-21 — — CN disclosed
CN-116323627-A Lipid compounds and lipid nanoparticle compositions 苏州艾博生物科技有限公司 2023-06-23 — — CN disclosed
CN-114206827-B Lipid nanoparticle compositions 苏州艾博生物科技有限公司 2023-05-23 — — CN disclosed
CN-114391008-A Lipid compounds and lipid nanoparticle compositions 苏州艾博生物科技有限公司 2022-04-22 — — CN disclosed
CN-114206827-A Lipid nanoparticle compositions 苏州艾博生物科技有限公司 2022-03-18 — — CN disclosed
CN-114206463-A Lipid compounds and lipid nanoparticle compositions 苏州艾博生物科技有限公司 2022-03-18 — — CN disclosed
CN-113271926-A Preparation of lipid nanoparticles and methods of administration thereof 摩登纳特斯有限公司 2021-08-17 — — CN disclosed
CN-111315359-A Method for preparing lipid nanoparticles 摩登纳特斯有限公司 2020-06-19 — — CN disclosed
Send feedback